Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Journal of Clinical Pathology|February 28, 2002
Clinically useful monoclonal antibodies in treatmentE Drewe, R J PowellRheumatology (Oxford, England)|February 22, 2003
Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patientsE Drewe, E M McDermott, P T Powell, et al.Rheumatology (Oxford, England)|August 19, 2004
Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndromeE Drewe, M L Huggins, A G Morgan, et al.Rheumatology (Oxford, England)|November 17, 2005
Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1AM L Nowlan, E Drewe, H Bulsara, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Thalidomide: current usesR J PowellAnnals of the Rheumatic Diseases|February 14, 1998
Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three casesM Duddridge, R J PowellBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Use of thalidomide in dermatological indicationsV Kontogiannis, R J PowellThe Journal of Surgical Research|December 1, 1996
Effect of aprotinin on smooth muscle cell proliferation, migration, and extracellular matrix synthesisJ Horodyski, R J PowellPageof 14